IBB vs VGK
iShares Biotechnology ETF vs Vanguard FTSE Europe ETF
- • VGK has the lower expense ratio at 0.06% vs 0.44% for IBB.
- • VGK pays a higher dividend yield (2.90%).
Side-by-side metrics
| Metric | IBB | VGK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.06% |
Dividend yield Trailing 12-month yield. | 0.22% | 2.90% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $37.86B |
YTD return | 16.44% | 7.41% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 0.90 |
P/E ratio | 24.79 | 17.85 |
Last price | $196.62 | $88.66 |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
VGK top holdings
| ASML.AS | ASML Holding NV | 3.97% |
| HSBA.L | HSBC Holdings PLC | 2.04% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.87% |
| NOVN.SW | Novartis AG Registered Shares | 1.83% |
| AZN.L | AstraZeneca PLC | 1.76% |
| NESN.SW | Nestle SA | 1.65% |
| SHEL.L | Shell PLC | 1.52% |
| SIE.DE | Siemens AG | 1.46% |
| SAP.DE | SAP SE | 1.18% |
| SAN.MC | Banco Santander SA | 1.16% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VGK
VGK (Vanguard FTSE Europe ETF) is European developed-market equities. Managed by Vanguard, the fund carries $37.9B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.90%. Its largest holding is ASML Holding NV (ASML.AS), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.